enGene Inc.
ENGN | NASDAQ
$1.96
+$0.05 (+2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$1.96
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Oct 30, 2025 | FY 2024 Oct 30, 2024 | FY 2023 Oct 30, 2023 | FY 2022 Oct 30, 2022 | FY 2021 Oct 30, 2021 | FY 2020 Oct 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -123.17M | -62.3M | -26.06M | -19.43M | -15.87M | -13.85M |
Interest Income | 9.43M | 10.41M | 1.12M | 129K | 25K | 56K |
Pretax Income | -117.3M | -55.16M | -99.9M | -24.44M | -23.44M | -15.07M |
Net Income | -117.3M | -55.14M | -99.92M | -24.46M | -23.44M | -15.07M |
Selling & General & Admin | 28.69M | 23.98M | 8.47M | 3.26M | 3.16M | 3.24M |
Research & Development | 94.48M | 38.32M | 16.46M | 15.47M | 12.46M | 10.61M |
Other Expenses | n/a | n/a | 1.13M | 700K | 253K | 636K |
Operating Expenses | 123.17M | 62.3M | 26.06M | 19.43M | 15.87M | 13.85M |
Interest Expense | 2.99M | 2.8M | 4.95M | 1.42M | 5.02M | 3.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 123.17M | 62.3M | 26.06M | 19.43M | 15.87M | 13.85M |
Income Tax Expense | n/a | -19K | 17K | 22K | n/a | n/a |
Shares Outstanding (Basic) | 51.12M | 44.64M | 23.56M | 15.81M | 15.81M | 15.81M |
Shares Outstanding (Diluted) | 51.12M | 44.64M | 23.56M | 15.81M | 15.81M | 15.81M |
EPS (Basic) | -2.29 | -1.46 | -4.24 | -1.84 | -0.01 | -0.95 |
EPS (Diluted) | -2.29 | -1.46 | -4.24 | -1.84 | -0.01 | -0.95 |
EBITDA | -113.8M | -52.04M | -94.77M | -22.78M | -18.15M | -12.9M |
EBIT | -114.31M | -52.36M | -94.95M | -23.02M | -18.42M | n/a |
Depreciation & Amortization | 509K | 323K | 175K | 238K | 272K | 259K |
Add to Watchlist
Select watchlists to add or remove ENGN